NGM

NGM
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.91
+1.51
+11.27%
Opening 12:47 04/07 EDT
OPEN
14.84
PREV CLOSE
13.40
HIGH
15.09
LOW
13.72
VOLUME
199.12K
TURNOVER
--
52 WEEK HIGH
22.95
52 WEEK LOW
8.81
MARKET CAP
1.01B
P/E (TTM)
-22.7495
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NGM stock price target is 28.60 with a high estimate of 32.00 and a low estimate of 23.00.

EPS

NGM News

More
  • Daily Insider Ratings Round Up 4/2/20
  • Seeking Alpha - Article · 2d ago
  • Insiders Who Are Calling A Bottom In Their Stock - Weekly Update (03/27/20 - 04/03/20)
  • Seeking Alpha - Article · 3d ago
  • Insiders Roundup: NGM, Legg Mason
  • GuruFocus.com · 3d ago
  • Daily Insider Ratings Round Up 3/25/20
  • Seeking Alpha - Article · 03/27 14:25

Industry

Biotechnology & Medical Research
+0.34%
Pharmaceuticals & Medical Research
+0.73%

Hot Stocks

Symbol
Price
%Change

About NGM

NGM Biopharmaceuticals, Inc.is a clinical-stage biopharmaceutical company developing novel therapeutics for the cardio-metabolic, liver, oncologic and ophthalmic diseases. The Company’s product candidates include NGM282, NGM313, NGM386, NGM395, NGM120, NGM217 and NGM621. NGM282 is an engineered variant of the human hormone known as FGF19, which the Company is developing for the treatment of non-alcoholic steatohepatitis (NASH). NGM313 is an agonistic antibody selectively activating fibroblast growth factor receptor 1c-beta-klotho and has the potential as an insulin sensitizer for the treatment of type two diabetes and NASH. NGM386 and NGM395 are engineered variants of the human hormone known as GDF15, which is developed for the treatment of obesity. NGM120 is an antagonistic antibody binding glial cell-derived neurotrophic factor receptor alpha-like, or GFRAL, that is designed to inhibit the effects of elevated GDF15 levels on cancer anorexia/cachexia syndrome, and cancer.
More

Webull offers kinds of NGM Biopharmaceuticals Inc stock information, including NASDAQ:NGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGM stock news, and many more online research tools to help you make informed decisions.